Glutaminyl Cyclase, Diseases, and Development of Glutaminyl
Por um escritor misterioso
Descrição
Full article: A patent review of glutaminyl cyclase inhibitors (2004–present)
Glutaminyl cyclase expression and pE-A in Alzheimer's disease
Glutaminyl cyclases, the potential targets of cancer and neurodegenerative diseases - ScienceDirect
IsoQC (QPCTL) knock-out mice suggest differential substrate conversion by glutaminyl cyclase isoenzymes
Glutaminyl cyclase inhibition leads to reduced binding of recombinant
Glutaminyl cyclase - Proteopedia, life in 3D
Glutaminyl Cyclase Inhibitor PQ912 Improves Cognition in Mouse Models of Alzheimer's Disease—Studies on Relation to Effective Target Occupancy
Human glutaminyl cyclase: Structure, function, inhibitors and involvement in Alzheimer's disease - ScienceDirect
Increased glutaminyl cyclase activity in brains of Alzheimer's disease individuals - Gunn - 2021 - Journal of Neurochemistry - Wiley Online Library
An overview of glutaminyl cyclase inhibitors for Alzheimer's disease
Some benzimidazole-based Glutaminyl Cyclase Inhibitors.
Regulation of MCP function by QPCTL and DPP4 a, Glutaminyl cyclase
Frontiers Development and evolution of human glutaminyl cyclase inhibitors (QCIs): an alternative promising approach for disease-modifying treatment of Alzheimer's disease
Therapeutic potential of glutaminyl cyclases: Current status and emerging trends - ScienceDirect
de
por adulto (o preço varia de acordo com o tamanho do grupo)
+(Disc+1)-image.jpg){kind=logo}
